Hadasit Bio Market Cap ($1.78 Million)
Market Cap & Net Worth: Hadasit Bio (HDST)
Hadasit Bio market cap. Hadasit Bio (TA:HDST) has a market capitalization of $1.78 Million (ILA665.31 Million) as of November 5, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30136 globally and #438 in its home market, demonstrating a -7.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hadasit Bio's stock price ILA60.00 by its total outstanding shares 11088500 (11.09 Million). Also see cash efficiency ratio of Hadasit Bio for how efficiently the company converts equity into cash flow.
Hadasit Bio Market Cap History (2015–2026)
Hadasit Bio market cap history from 2015 to 2026. Data shows change from $66.65 Million to $1.78 Million (-28.33% CAGR). Check Hadasit Bio stock price for real-time trading data and today's change.
Hadasit Bio Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hadasit Bio's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HDST net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
480.82x
Hadasit Bio's market cap is 480.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.88 Million | $360.00K | $13.17 Million | 19.12x | 0.52x |
| 2018 | $11.16 Million | $250.00K | -$316.00K | 44.64x | N/A |
| 2019 | $11.06 Million | $23.00K | -$22.30 Million | 480.82x | N/A |
Competitor Companies of HDST by Market Capitalization
Companies near Hadasit Bio in the global market cap rankings as of November 5, 2026. Also see HDST asset base for a full breakdown of the balance sheet.
Key companies related to Hadasit Bio by market ranking:
- Peptron Inc (KQ:087010): Ranked #8741 globally with a market cap of $973.22 Million USD ( ₩1.44 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #19020 globally with a market cap of $100.18 Million USD ( ₩147.83 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19385 globally with a market cap of $90.78 Million USD ( ₩133.96 Billion KRW).
- Cell Biotech Co. Ltd (KQ:049960): Ranked #20003 globally with a market cap of $77.90 Million USD ( ₩114.95 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #8741 | Peptron Inc | KQ:087010 | $973.22 Million | ₩93700.00 |
| #19020 | Bioneer Corporation | KQ:064550 | $100.18 Million | ₩6690.00 |
| #19385 | MEDIPOST Co. Ltd | KQ:078160 | $90.78 Million | ₩8710.00 |
| #20003 | Cell Biotech Co. Ltd | KQ:049960 | $77.90 Million | ₩14890.00 |
Market Capitalization of Hadasit Bio (2015–2026)
Market capitalization of Hadasit Bio from 2015 to today. Between 2015 and today, Hadasit Bio's market cap moved from $66.65 Million to $ 1.78 Million, with a yearly change of -28.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.78 Million | +96.08% |
| 2025 | ILA909.67K | -41.15% |
| 2024 | ILA1.55 Million | -22.39% |
| 2023 | ILA1.99 Million | -47.24% |
| 2022 | ILA3.78 Million | -61.86% |
| 2021 | ILA9.90 Million | -42.69% |
| 2020 | ILA17.27 Million | +56.18% |
| 2019 | ILA11.06 Million | -0.91% |
| 2018 | ILA11.16 Million | +62.16% |
| 2017 | ILA6.88 Million | +52.30% |
| 2016 | ILA4.52 Million | -93.22% |
| 2015 | ILA66.65 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Hadasit Bio was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.78 Million USD |
| MoneyControl | $1.78 Million USD |
| MarketWatch | $1.78 Million USD |
| marketcap.company | $1.78 Million USD |
| Reuters | $1.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hadasit Bio
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings L… Read more